Revised outcome With reference to our earlier letter dated April 16, 2026, in this connection we would like to submit the revised outcome of the Board Meeting as follows: 1. Convening ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gennex Laboratories Ltd held a board meeting on April 16, 2026, which was revised and submitted on April 17, 2026. The board has called an Extraordinary General Meeting on May 12, 2026, at 12:30 PM via video conferencing. The purpose is to regularize the appointment of Ms. Khushbu Kachhawa as a Non-Executive Independent Woman Director. NSDL has been appointed as the authorized agency for facilitating the EGM and providing e-voting facilities. Ms. Sweety Kapoor, a Practicing Company Secretary from Kolkata, has been appointed as the Scrutinizer. E-voting will be open from May 8, 2026 (9:00 AM) to May 11, 2026 (5:00 PM), with May 1, 2026 as the cut-off date for determining shareholder eligibility.
This is a routine corporate governance action where the company is seeking shareholder approval to formally appoint an additional director. Positive shareholder response to the appointment could signal confidence in the board's composition and strengthen governance structure.